Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Torp Rahbek

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
British Journal of Clinical Pharmacology|December 20, 2025
Screening real-world data for evidence of unsuspected drug benefits: An application of the sequence symmetry analysisMartin Torp Rahbek, Lars Christian Lund, Jesper Hallas
Pharmacoepidemiology and Drug Safety|November 1, 2023
Trend adjustment of the sequence difference when performing sequence symmetry analysesMartin Torp Rahbek, Jesper Hallas, Lars Christian Lund
Pharmacoepidemiology and Drug Safety|May 20, 2025
Obtaining Valid Compatibility Intervals for Sequence Symmetry Analyses Utilizing Active Comparators: A Simulation StudyMartin Torp Rahbek, Jesper Hallas, Lars Christian Lund
Pharmacoepidemiology and Drug Safety|August 10, 2023
A case for screening real-world data for collateral drug benefits: Glucagon-like peptide 1 receptor agonists and bile acid diarrheaMartin Torp Rahbek, Lars Christian Lund, Jesper Hallas
Scandinavian Journal of Clinical and Laboratory Investigation|March 8, 2018
Transient plasma cobalamin elevation in patients with pneumonia - two case reportsMartin Torp Rahbek, Rudolf Scheller, Mads Nybo, et al.
Alzheimer'S Research & Therapy|April 29, 2026
Acetylcholinesterase inhibitors and the risk of delirium - a Danish nationwide register-based cohort studyMartin Torp Rahbek, Helene Kildegaard, Jesper Hallas, et al.
Pharmacoepidemiology and Drug Safety|March 7, 2024
Is the sequence ratio an unbiased estimate of the incidence rate ratio? A simulation studyThomas Delvin, Sofie Egsgaard, Jesper Hallas, et al.
European Journal of Haematology|September 23, 2023
Mortality and clinical outcomes following SARS-CoV-2 infection among individuals with haematological malignancies: A Danish population-based cohort studyLars Christian Lund, Martin Torp Rahbek, Peter Brown, et al.
JAMA Network Open|May 13, 2022
Analysis of Antiemetic Use After Initiation of Hormone TherapyMartin Torp Rahbek, Erika Angelica Björkström Gram, Jesper Hallas, et al.
Journal of Internal Medicine|October 23, 2024
Increased risk of hypereosinophilia following initiation of glucagon-like peptide 1 receptor agonist: A symmetry analysis using the Danish health registriesMartin Torp Rahbek, Søren Andreas Just, Kasper Bruun Kristensen, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
British Journal of Clinical Pharmacology|December 20, 2025
Screening real-world data for evidence of unsuspected drug benefits: An application of the sequence symmetry analysisMartin Torp Rahbek, Lars Christian Lund, Jesper Hallas
Pharmacoepidemiology and Drug Safety|November 1, 2023
Trend adjustment of the sequence difference when performing sequence symmetry analysesMartin Torp Rahbek, Jesper Hallas, Lars Christian Lund
Pharmacoepidemiology and Drug Safety|May 20, 2025
Obtaining Valid Compatibility Intervals for Sequence Symmetry Analyses Utilizing Active Comparators: A Simulation StudyMartin Torp Rahbek, Jesper Hallas, Lars Christian Lund
Pharmacoepidemiology and Drug Safety|August 10, 2023
A case for screening real-world data for collateral drug benefits: Glucagon-like peptide 1 receptor agonists and bile acid diarrheaMartin Torp Rahbek, Lars Christian Lund, Jesper Hallas
Scandinavian Journal of Clinical and Laboratory Investigation|March 8, 2018
Transient plasma cobalamin elevation in patients with pneumonia - two case reportsMartin Torp Rahbek, Rudolf Scheller, Mads Nybo, et al.
Alzheimer'S Research & Therapy|April 29, 2026
Acetylcholinesterase inhibitors and the risk of delirium - a Danish nationwide register-based cohort studyMartin Torp Rahbek, Helene Kildegaard, Jesper Hallas, et al.
Pharmacoepidemiology and Drug Safety|March 7, 2024
Is the sequence ratio an unbiased estimate of the incidence rate ratio? A simulation studyThomas Delvin, Sofie Egsgaard, Jesper Hallas, et al.
European Journal of Haematology|September 23, 2023
Mortality and clinical outcomes following SARS-CoV-2 infection among individuals with haematological malignancies: A Danish population-based cohort studyLars Christian Lund, Martin Torp Rahbek, Peter Brown, et al.
JAMA Network Open|May 13, 2022
Analysis of Antiemetic Use After Initiation of Hormone TherapyMartin Torp Rahbek, Erika Angelica Björkström Gram, Jesper Hallas, et al.
Journal of Internal Medicine|October 23, 2024
Increased risk of hypereosinophilia following initiation of glucagon-like peptide 1 receptor agonist: A symmetry analysis using the Danish health registriesMartin Torp Rahbek, Søren Andreas Just, Kasper Bruun Kristensen, et al.
Pageof 2